- Home
- IKT vs DSP Comparison
IKT vs DSP Comparison
Compare IKT & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- DSP
- Stock Information
- Founded
- IKT 2008
- DSP 1999
- Country
- IKT United States
- DSP United States
- Employees
- IKT N/A
- DSP N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- DSP EDP Services
- Sector
- IKT Health Care
- DSP Technology
- Exchange
- IKT Nasdaq
- DSP Nasdaq
- Market Cap
- IKT 123.7M
- DSP 142.1M
- IPO Year
- IKT 2020
- DSP 2021
- Fundamental
- Price
- IKT $1.53
- DSP $8.64
- Analyst Decision
- IKT Buy
- DSP Strong Buy
- Analyst Count
- IKT 2
- DSP 10
- Target Price
- IKT $8.00
- DSP $19.85
- AVG Volume (30 Days)
- IKT 96.5K
- DSP 322.7K
- Earning Date
- IKT 11-13-2025
- DSP 11-11-2025
- Dividend Yield
- IKT N/A
- DSP N/A
- EPS Growth
- IKT N/A
- DSP N/A
- EPS
- IKT N/A
- DSP 0.13
- Revenue
- IKT N/A
- DSP $318,471,000.00
- Revenue This Year
- IKT N/A
- DSP $16.44
- Revenue Next Year
- IKT N/A
- DSP $15.32
- P/E Ratio
- IKT N/A
- DSP $64.59
- Revenue Growth
- IKT N/A
- DSP 30.92
- 52 Week Low
- IKT $1.42
- DSP $8.11
- 52 Week High
- IKT $4.20
- DSP $26.33
- Technical
- Relative Strength Index (RSI)
- IKT 41.85
- DSP 46.38
- Support Level
- IKT $1.53
- DSP $8.16
- Resistance Level
- IKT $1.67
- DSP $9.29
- Average True Range (ATR)
- IKT 0.11
- DSP 0.38
- MACD
- IKT -0.00
- DSP 0.10
- Stochastic Oscillator
- IKT 19.64
- DSP 44.49
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.